Drug Safety Oversight Board Will Require Two-Thirds Majority For Recommendations
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA's Drug Safety Oversight Board will need a two-thirds majority of a quorum to make recommendations, a Center for Drug Evaluation & Research Manual of Policies & Procedures states
You may also be interested in...
FDA Has Its Own Peer Review Process, Gottlieb Says
FDA Deputy Commissioner Gottlieb defends agency decision-making practices in face of criticism from medical journals.
FDA Has Its Own Peer Review Process, Gottlieb Says
FDA Deputy Commissioner Gottlieb defends agency decision-making practices in face of criticism from medical journals.
Drug Safety Oversight Board Proceedings Should Be More Open, Rep. DeLauro Says
FDA Commissioner Crawford defends the board as an "instrument of openness" in response to complaints that the panel's closed proceedings will fail to provide greater transparency.